Ledger.Open graph →

SEC Form D · filed July 6, 2020

DTx Pharma, Inc

Offering

$5.0M

Sold

$200K

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

SAN DIEGO, CA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Jeffrey T. Friedman · San Diego, CAExec · Director John T. Grundy · San Diego, CADirector Arthur T. Suckow · San Diego, CAExec · Director Sanket Wani · Malvern, PAExec · Director Daniel C. Davis · Campbell, CAExec · Director High Traverse Development, LLC · Salt Lake City, UTDirector Michael J. Holmberg · Chicago, ILExec · Director Sam Konz · New York, NYExec · Director Eric Felder · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗